| Original language | English |
|---|---|
| Article number | 558 |
| Journal | Trials |
| Volume | 17 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published (VoR) - 24 Nov 2016 |
Funding
The G-TOG trial is funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme. The funder’s reference for the trial is 12/127/10. The trial is sponsored by University Hospitals Birmingham NHS Foundation Trust (UHBFT). Standard NHS Indemnity applies. C Brittain, M Childs, L Duley, T Hepburn, G Meakin, A Montgomery and W Tan are all employed by the University of Nottingham. External funding for all authors on this project is funded by the National Institute for Health Research (NIHR).
Keywords
- Ceftriaxone
- Gentamicin
- Gonorrhoea
- Noninferiority
- Randomised trial
- Resistance
- Treatment